EP3673889A1 - Medizinischer infusionsbeutel - Google Patents

Medizinischer infusionsbeutel Download PDF

Info

Publication number
EP3673889A1
EP3673889A1 EP18848824.1A EP18848824A EP3673889A1 EP 3673889 A1 EP3673889 A1 EP 3673889A1 EP 18848824 A EP18848824 A EP 18848824A EP 3673889 A1 EP3673889 A1 EP 3673889A1
Authority
EP
European Patent Office
Prior art keywords
chemical
chamber
main chamber
accommodated
medical solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP18848824.1A
Other languages
English (en)
French (fr)
Other versions
EP3673889A4 (de
Inventor
Kwang Soo Park
Ki Pyo Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HK Inno N Corp
Original Assignee
CJ Healthcare Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CJ Healthcare Corp filed Critical CJ Healthcare Corp
Publication of EP3673889A1 publication Critical patent/EP3673889A1/de
Publication of EP3673889A4 publication Critical patent/EP3673889A4/de
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/202—Separating means
    • A61J1/2027—Separating means having frangible parts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10—Bag-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2089—Containers or vials which are to be joined to each other in order to mix their contents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2093—Containers having several compartments for products to be mixed

Definitions

  • the present invention relates to a medical solution bag, and more particularly to a medical solution bag that includes an auxiliary chamber, in which a chemical is accommodated, in addition to a main chamber, in which a solution is accommodated, such that the chemical accommodated in the auxiliary chamber is easily additionally injected when the solution accommodated in the main chamber is injected as the chemical is simply mixed with the solution.
  • a medical solution such as a physiological sodium chloride solution or glucose is kept in a solution container having a predetermined shape.
  • the solution container is generally formed to have a bottle shape.
  • the solution container having a bottle shape that is, the solution bottle is formed of glass, and because it is easily broken by an impact due to the characteristics of the material, it is difficult to treat it.
  • the solution bag is formed of a flexible material such as a synthetic resin film, it is easy to treat it because it can be hardly damaged due to the characteristics of the material.
  • an amino acid solution and a glucose solution are mixed and kept they are browned, if a fatty oil and an electrolyte solution are mixed and kept, the fatty components are condensed, and if a phosphoric acid-containing liquid and a calcium-containing liquid are mixed and kept, calcium phosphate is precipitated.
  • a conventional medical solution bag A' having multiple chambers has a plurality of main chambers 10' that are separated and partitioned by sealing parts 110' in a body 100', the different kinds of solutions are prevented from being mixed as the solutions are accommodated in the main chambers 10', respectively.
  • sealing parts 110' that separate and partition the plurality of main chambers are simply separated by applying an appropriate pressure, the sealing parts 110' are separated shortly before the solutions are injected so that the mixed solutions can be injected as the different kinds of solutions accommodated in the main chambers 10', respectively, are mixed.
  • the medical solution bag having multiple chambers can prevent the solutions from being mixed when being kept, but it is troublesome to additionally inject a chemical such as a vitamin agent in the solution injecting process.
  • the medical solution bag having multiple chambers cannot additionally accommodate a chemical in addition to the solutions accommodated in the main chambers, and when a chemical is to be additionally injected in addition to the solutions accommodated in the main chambers, preparation of an additional member such as preparation of a separate injection needle is necessary, which is troublesome.
  • the present invention has been made in an effort to solve the above-mentioned problems, and provides a medical solution bag that can solve a problem of having a troublesomeness of providing an injection needle because the injection needle has to be used when a chemical is additionally injected because a chemical except for solutions accommodated in main chambers cannot be used when a conventional medical solution bag having multiple chambers are used.
  • a medical solution bag including: a main chamber in which a solution is accommodated in a bag-shaped body thereof; a main port configured to interrupt discharge of the solution from the interior to the outside of the main chamber; and an auxiliary chamber including an auxiliary body in which a chemical, the kind of which is different from the solution accommodated in the main chamber, is separately accommodated, a connection member extending from the interior of the auxiliary body to the interior of the main chamber, and an interruption member configured to interrupt discharge of the chemical through the connection member.
  • the main chamber may be separated and partitioned by a sealing part formed to cross the interior of the body.
  • the sealing part may be separated through pressing.
  • the main port may be coupled to the separated/partitioned areas of the main chamber.
  • the interruption member may be formed at one end of the connection member connected to the inside of the auxiliary body to have a form of a cap.
  • the interruption member having the form of a cap may include a breaking part that is broken through pressing.
  • the thickness of the breaking part may be smaller than those of the other parts.
  • the interruption member may be formed in the auxiliary body to have a form of a sealing part that is separated through pressing.
  • connection member may be coupled to the main chamber and the auxiliary chamber through thermal fusion or high-frequency fusion.
  • An outer surface of the auxiliary chamber may be surrounded by a light-shielding film.
  • the medical solution bag according to the present invention includes an auxiliary chamber, in which a chemical is separately accommodated, in addition to main chambers, in which a solution is accommodated, and because the solutions and the chemical are simply mixed by introducing the chemical in the auxiliary chamber into the main chamber, the chemical can be easily injected in addition to the solutions.
  • a medical solution bag A includes a main chamber 10, a main port 20, and an auxiliary chamber 30.
  • a solution (not denoted by a reference numeral) is accommodated in a bag-shaped body 100.
  • the main chamber 10, as illustrated in FIG. 7 may be separated and partitioned by a sealing part 110 formed to cross the interior of the body 100.
  • the sealing part 110 may be separated through pressing.
  • the mixed solution may be injected.
  • a plurality of sealing parts 110 may be formed, and because the number of the separated/partitioned areas of the main chamber 10 increases if the plurality of sealing parts 110 are formed, more various kinds of solutions may be accommodated through the main chamber 10.
  • the main port 20 interrupts discharge of the solution from the interior to the outside of the main chamber 10.
  • the main port 20 may be coupled to the separated/partitioned areas of the main chamber 10.
  • the solutions accommodated in the separated/partitioned areas of the main chamber 10 may be individually injected through the main port 20.
  • a main port 20 having any scheme that may interrupt discharge of the solutions accommodated in the main chamber 10 is sufficient, and an example thereof may be an injection port into which an injection needle is inserted or an infusion port into which a spike is inserted.
  • the auxiliary chamber 30 includes an auxiliary body 31 in which a chemical, the kind of which is different from the solution accommodated in the main chamber 10, is separately accommodated, a connection member 32 extending from the interior of the auxiliary body 31 to the interior of the main chamber 10, and an interruption member 33 and 33' configured to interrupt discharge of the chemical through the connection member 32.
  • the interruption member 33 and 33' is opened, the chemical accommodated in the auxiliary body 31 is introduced into the interior of the main chamber 10 via the connection member 32.
  • the interruption member 33 may be formed at one end of the connection member 32 connected to the inside of the auxiliary body 31 in a form of a cap.
  • the interruption member 33 formed in the form of a cap can prevent unintended discharge of the chemical because it blocks an inlet of the connection member 32.
  • the interruption member 33 formed in the form of a cap may include a breaking part 33a.
  • connection member 32 located in the interior of the auxiliary body 31 is opened as the breaking part 33a is broken, the chemical in the auxiliary chamber 30 can be simply introduced into the interior of the main chamber 10 via the connection member 32.
  • the thickness of the breaking part 33a is relatively small as compared with the thicknesses of the other parts, it may be easily broken through pressing.
  • the interruption member 33' may be formed in a form of a sealing part that crosses the interior of the auxiliary body 31.
  • the interruption member 33' formed in the form of a sealing part can prevent unintended discharge of the chemical because it interrupts introduction of the chemical to the inlet of the connection member 32.
  • the interruption member 33' formed to have a form of a sealing part can be collapsed through pressing.
  • the chemical in the interior of the auxiliary chamber 30 is introduced into the inlet of the connection member 32 as the interruption member 33' formed in the form of a sealing part is pressed and collapsed, the chemical in the auxiliary chamber 30 can be simply introduced into the interior of the main chamber 10 via the connection member 32.
  • connection member 32 is coupled to the main chamber 10 and the auxiliary chamber 30 through thermal fusion and high-frequency fusion to maintain a sealing state at a coupling portion of the connection member 32 due to the characteristics of the coupling scheme, leakage of the solution and the chemical through the coupling portion of the connection member 32 can be prevented.
  • the main port 20 extends from the interior to the outside of the main chamber 10, and because an injection needle or a spike is inserted into one end of the outside of the main port 20, the solution accommodated in the main chamber 10 through the main port 20 may be injected.
  • auxiliary chamber 30 including an auxiliary body 31 in which a chemical, the kind of which is different from the solution accommodated in the main chamber 10, is separately accommodated, a connection member 32 extending from the interior of the auxiliary body 31 to the interior of the main chamber 10, and an interruption member 33 and 33' configured to interrupt discharge of the chemical through the connection member 32, and because the chemical is introduced into the interior of the main chamber 10 via the connection member 32 as the interruption member 33 and 33' is opened, the chemical can be smoothly additionally injected as the chemical may be simply mixed with the solutions.
  • the interruption member 33 includes the breaking part 33a that is formed in a form of a cap and has a thickness that is smaller than those of the other parts, and as illustrated in FIG. 2 , because the chemical in the interior of the auxiliary chamber 30 is introduced into the main chamber 10 via the connection member 32 as the breaking part 33a is broken, the chemical in the auxiliary chamber 30 can be simply introduced into the interior of the main chamber 10, the chemical accommodated in the auxiliary chamber 30 can be smoothly additionally injected together with the solutions accommodated in the main chambers 10 by simply mixing the solution and the chemical.
  • the interruption member 33' includes the breaking part 33a that is formed in a form of a sealing part and is collapsed through pressing, and as illustrated in FIG. 6 , because the chemical in the interior of the auxiliary chamber 30 is introduced into the main chamber 10 via the connection member 32 as the interruption member 33' is collapsed, the chemical in the auxiliary chamber 30 can be simply introduced into the interior of the main chamber 10, the chemical accommodated in the auxiliary chamber 30 can be smoothly additionally injected together with the solutions accommodated in the main chambers 10 by simply mixing the solution and the chemical.
  • the medical solution bag A includes the auxiliary chamber 30, in which the chemical is separately accommodated, in addition to the main chamber 10, in which the solution is accommodated, and because the solutions and the chemical are simply mixed by introducing the chemical in the auxiliary chamber 30 into the main chamber 10, the chemical can be easily additionally injected when the solution is injected.

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Fluid Mechanics (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
EP18848824.1A 2017-08-25 2018-08-24 Medizinischer infusionsbeutel Withdrawn EP3673889A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020170107809A KR101964383B1 (ko) 2017-08-25 2017-08-25 의료용 수액백
PCT/KR2018/009797 WO2019039906A1 (ko) 2017-08-25 2018-08-24 의료용 수액백

Publications (2)

Publication Number Publication Date
EP3673889A1 true EP3673889A1 (de) 2020-07-01
EP3673889A4 EP3673889A4 (de) 2021-05-19

Family

ID=65439057

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18848824.1A Withdrawn EP3673889A4 (de) 2017-08-25 2018-08-24 Medizinischer infusionsbeutel

Country Status (4)

Country Link
EP (1) EP3673889A4 (de)
KR (1) KR101964383B1 (de)
CN (1) CN111050728A (de)
WO (1) WO2019039906A1 (de)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3834566A1 (de) * 1988-10-11 1990-04-12 Fresenius Ag Behaelter zur sterilen, getrennten aufbewahrung mindestens zweier substanzen und zur vermischung derselben
JP2000167022A (ja) * 1998-12-04 2000-06-20 Showa Denko Kk 複室医療容器
JP2001009006A (ja) * 1999-06-29 2001-01-16 Terumo Corp 複室容器
JP2003275280A (ja) * 2002-03-26 2003-09-30 Showa Denko Plastic Products Co Ltd 輸液容器用遮光カバー
US7175614B2 (en) * 2002-10-17 2007-02-13 Baxter International Inc. Peelable seal
US7789852B2 (en) * 2004-11-26 2010-09-07 Hosokawa Yoko Co., Ltd. Medical liquid container and preparation-containing medical liquid container
KR101510084B1 (ko) * 2007-04-27 2015-04-10 아지노모토 가부시키가이샤 복실 용기
DE102007028733A1 (de) * 2007-06-21 2008-12-24 Fresenius Kabi Deutschland Gmbh Behältnis zur Verwendung in der enteralen Ernährung
KR100946349B1 (ko) 2008-03-28 2010-03-08 이영옥 수액백
CN201578565U (zh) * 2010-01-14 2010-09-15 廖大中 带有预混药袋的输液瓶
KR101124328B1 (ko) * 2010-05-10 2012-03-16 (주)메디파마플랜 다중챔버를 갖는 의료용 수액백 키트
ES2629294T3 (es) * 2014-07-02 2017-08-08 Paolo Gobbi Frattini S.R.L. Envase flexible con una cámara estéril y hermética para la reconstitución y la administración de sustancias medicinales o nutricionales fluidas instilables en el cuerpo de un paciente
KR101611859B1 (ko) * 2015-04-24 2016-04-14 제이더블유케미타운 주식회사 혼합형 다중 챔버 용기
CN205459877U (zh) * 2016-01-28 2016-08-17 成都艾比科生物科技有限公司 一种多腔室防倒流输液袋

Also Published As

Publication number Publication date
KR101964383B1 (ko) 2019-04-01
KR20190022057A (ko) 2019-03-06
EP3673889A4 (de) 2021-05-19
CN111050728A (zh) 2020-04-21
WO2019039906A1 (ko) 2019-02-28

Similar Documents

Publication Publication Date Title
JP3205560U (ja) 点滴液容器とともに使用するための液体移送デバイス
EP3191226B1 (de) Behälter und verschluss
BRPI0415438B8 (pt) conector para embalagens contendo líquido médico
KR20040086373A (ko) 의료용 복실 용기
EP3932452B1 (de) Vorgefüllte spritze, verfahren zur herstellung einer vorgefüllten spritze und verfahren zur vergrösserung der oberfläche
EP1070495A3 (de) Medizinischer Mehrkammerbehälter und Verfahren zu seiner Herstellung
US8764703B2 (en) Pre-filled syringe
US12390398B2 (en) Connector for a medical container
WO2012133131A1 (ja) コネクタ
KR102370973B1 (ko) 일체형 니들리스 커넥터
WO2017164231A1 (ja) 薬剤容器用ゴム栓、薬剤収納済薬剤容器および薬剤容器セット
EP3603603B1 (de) Hohlspritze und spritzenset
EP3673890A1 (de) Medizinischer infusionsbeutel
KR101964383B1 (ko) 의료용 수액백
JP5594687B2 (ja) 薬剤排出具、及び薬剤排出具を用いた複室容器
JP4412468B2 (ja) 医療用混合型薬液封止体および封止方法
CN110025484A (zh) 一种药剂药液隔离的一体式药瓶
CN104257496A (zh) 一次性肝素钠生理盐水封管液套装
JP2009154024A (ja) 複室容器
JPH08141091A (ja) ２室式容器兼用注射器
CN208598807U (zh) 一种输液容器用双柱式组合盖
WO2021101794A1 (en) Drug delivery systems including displaceable closures
KR20070020845A (ko) 약액 주입 세트
HK1249005B (en) Connector for a medical container
KR20150120796A (ko) 주사기용 시린지 및 그를 포함한 주사기용 시린지 세트

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20200228

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: HK INNO.N CORPORATION

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20210416

RIC1 Information provided on ipc code assigned before grant

Ipc: A61J 1/20 20060101AFI20210412BHEP

Ipc: A61J 1/10 20060101ALI20210412BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20230523

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20231003